Bulletin de la Dialyse à Domicile

French translation of 2026 ISPD Position Statement on tracking and reporting loss from PD therapy

Annabel Boyer, Max Dratwa, Christian Verger — Mon, 14 Sep 2026 00:00:00 +0200

In accordance with the partnership agreement between the ISPD and the RDPLF (https://doi.org/10.25796/bdd.v4i3.63033), the RDPLF is the official French translator of the ISPD's guidelines.

The RDPLF is committed to providing a faithful translation of the original text under the supervision of renowned nephrologists who are experts in the field. The translation is available on the ISPD website and in the Bulletin de la Dialyse à Domicile.

Like the original text, the translation can be downloaded free of charge under a CC BY 4.0 licence: https://creativecommons.org/licenses/by-nc/4.0/.

The aim of this translation is to help French-speaking professionals familiarise themselves with the ISPD’s recommendations in their mother tongue. Any reference in an article must be made to the original open-access text: https://doi.org/10.1177/08968608261461639. For articles written for French journals, keep the reference to the original English text, but also include the following: 'French translation: https://doi.org/10.25796/bdd.v9i3.87129.

The status of peritoneal dialysis in mainland France and Belgium: RDPLF Annual Report 2026

Mon, 14 Sep 2026 00:00:00 +0200

In this report, the RDPLF (the French-Language Registry of Peritoneal Dialysis and Home Hemodialysis) presents the profiles and trends relating to patients undergoing peritoneal dialysis in Belgium and mainland France in 2025. In France, the data is over 90 per cent complete, whereas in Belgium, it is primarily representative of Wallonia and Brussels, with Flanders being less well represented. This descriptive analysis is based on the main database module and focuses on prevalent patients in 2025 as well as incident patients from 2023–2024 for the actuarial analyses.

As of December 31, 2025, the RDPLF was monitoring 2,346 French patients and 346 Belgian patients. The average age at the start of peritoneal dialysis (PD) was 66.5 years in France and 63.4 years in Belgium. The majority of patients had started PD as a primary treatment: 80.8 per cent in France and 75.9 per cent in Belgium.

The practices differed slightly. In France, continuous ambulatory peritoneal dialysis (CAPD) predominated (56.2 per cent), accounting for 82.8 per cent of patients receiving assistance from a nurse. In Belgium, automated peritoneal dialysis (APD) was the most common modality (70.3 per cent), with the patients including those receiving assistance. Receiving assistance from a care worker was also more common in Belgium (12 per cent compared with 5 per cent in France). Changes in treatment modality remained frequent in both countries even after the 90th day.

The number of patients decreased in both countries in 2025: by 4.6 per cent in France and by 1.2 per cent in Belgium. Transfers to hemodialysis accounted for 28.37 per 100 patient-years in France and 21.68 per 100 patient-years in Belgium. The median peritonitis-free survival period was 32 months in both countries.

Icodextrin was used more frequently in France. These differences in profiles and practices could form the basis for further comparative analyses.

Brown tumors revealed by SPECT/CT in a dialysis patient presenting with progressive neuropathic lower limb pain

Mon, 14 Sep 2026 00:00:00 +0200

Background: Brown tumors are benign osteolytic lesions caused by excessive bone resorption in severe and prolonged hyperparathyroidism. Although uncommon in patients undergoing dialysis, they should be considered in cases of severe refractory hyperparathyroidism and unexplained focal pain. Whole-body bone scintigraphy combined with single-photon emission computed tomography/computed tomography (SPECT/CT) may be particularly useful for detecting and localizing multifocal skeletal involvement.

Case Presentation: We report the case of a 46-year-old man with end-stage kidney disease on hemodialysis and severe refractory hyperparathyroidism who presented with progressive neuropathic pain in the right lower limb. Whole-body bone scintigraphy showed multiple areas of increased tracer uptake involving both tibias and distal femurs. SPECT/CT localized these abnormalities to bilateral intramedullary tibial lesions, consistent with multifocal brown tumors. The right tibial lesion corresponded to the symptomatic site. Revision parathyroidectomy was subsequently performed, resulting in rapid and marked symptomatic improvement.

Conclusion: This case highlights that brown tumors should be considered in the differential diagnosis of dialysis patients with unexplained focal neuropathic pain and severe refractory hyperparathyroidism. Whole-body bone scintigraphy combined with SPECT/CT is particularly valuable by demonstrating the extent of skeletal involvement and providing precise anatomical localization with clinicoradiological correlation. Recognition of multifocal brown tumors may facilitate appropriate management of the underlying severe refractory hyperparathyroidism.